Genpact Limited Reports Director Changes and Officer Compensation Updates
Ticker: G · Form: 8-K · Filed: Sep 12, 2025 · CIK: 1398659
| Field | Detail |
|---|---|
| Company | Genpact LTD (G) |
| Form Type | 8-K |
| Filed Date | Sep 12, 2025 |
| Risk Level | low |
| Pages | 2 |
| Reading Time | 2 min |
| Key Dollar Amounts | $0.01 |
| Sentiment | neutral |
Sentiment: neutral
Topics: governance, executive-compensation, board-of-directors
TL;DR
Genpact board shakeup and exec pay changes announced.
AI Summary
Genpact Limited announced on September 11, 2025, changes in its board and executive compensation. Specifically, the company reported the departure of a director and the election of a new director, alongside updates to the compensatory arrangements for certain officers.
Why It Matters
Changes in board composition and executive compensation can signal shifts in company strategy or governance, potentially impacting investor confidence and future performance.
Risk Assessment
Risk Level: low — The filing reports routine corporate governance changes and compensation adjustments, which are common and typically do not indicate significant operational risks.
Key Numbers
- 001-33626 — SEC File Number (Identifies the company's filing history with the SEC.)
- 98-0533350 — I.R.S. Employer Identification No. (Company's tax identification number.)
Key Players & Entities
- Genpact Limited (company) — Registrant
- September 11, 2025 (date) — Date of earliest event reported
- Bermuda (location) — State or other jurisdiction of incorporation
- Canon's Court, 22 Victoria Street Hamilton HM 12 (address) — Address of Principal Executive Offices
FAQ
Who is the departing director and who is the newly elected director?
The filing does not specify the names of the departing or newly elected directors.
What specific changes were made to the compensatory arrangements for certain officers?
The filing indicates that there were updates to compensatory arrangements but does not detail the specific changes.
What is the effective date of these changes?
The earliest event reported is dated September 11, 2025.
What is Genpact Limited's jurisdiction of incorporation?
Genpact Limited is incorporated in Bermuda.
What is the company's principal executive office address?
The principal executive offices are located at Canon's Court, 22 Victoria Street, Hamilton HM 12, Bermuda.
Filing Stats: 478 words · 2 min read · ~2 pages · Grade level 11.9 · Accepted 2025-09-12 17:04:07
Key Financial Figures
- $0.01 — ch registered Common shares, par value $0.01 per share G New York Stock Exchange I
Filing Documents
- g-20250911.htm (8-K) — 26KB
- 0001398659-25-000103.txt ( ) — 140KB
- g-20250911.xsd (EX-101.SCH) — 2KB
- g-20250911_lab.xml (EX-101.LAB) — 22KB
- g-20250911_pre.xml (EX-101.PRE) — 13KB
- g-20250911_htm.xml (XML) — 3KB
From the Filing
g-20250911 UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 FORM 8-K CURRENT REPORT Pursuant to Section 13 or 15(d) of the Securities Exchange Act of 1934 Date of Report (Date of earliest event reported): September 11, 2025 GENPACT LIMITED (Exact name of registrant as specified in its charter) Bermuda 001-33626 98-0533350 (State or other jurisdiction of incorporation) (Commission File Number) (I.R.S. Employer Identification No.) Canon's Court, 22 Victoria Street Hamilton HM 12 , Bermuda (Address of Principal Executive Offices) (Zip Code) Registrant's telephone number, including area code: ( 441 ) 298-3300 Not Applicable (Former name or former address, if changed since last report) Check the appropriate box below if the Form 8-K filing is intended to simultaneously satisfy the filing obligation of the registrant under any of the following provisions: Written communications pursuant to Rule 425 under the Securities Act (17 CFR 230.425) Soliciting material pursuant to Rule 14a-12 under the Exchange Act (17 CFR 240.14a-12) Pre-commencement communications pursuant to Rule 14d-2(b) under the Exchange Act (17 CFR 240.14d-2(b)) Pre-commencement communications pursuant to Rule 13e-4(c) under the Exchange Act (17 CFR 240.13e-4(c)) Securities registered pursuant to Section 12(b) of the Act: Title of each class Trading Symbol Name of each exchange on which registered Common shares, par value $0.01 per share G New York Stock Exchange Indicate by check mark whether the registrant is an emerging growth company as defined in Rule 405 of the Securities Act of 1933 (230.405 of this chapter) or Rule 12b-2 of the Securities Exchange Act of 1934 (240.12b-2 of this chapter). Emerging growth company If an emerging growth company, indicate by check mark if the registrant has elected not to use the extended transition period for complying with any new or revised financial accounting standards provided pursuant to Section 13(a) of the Exchange Act. Item 5.02 Departure of Directors or Certain Officers; Election of Directors; Appointment of Certain Officers; Compensatory Arrangements of Certain Officers. On September 11, 2025, Genpact Limited (the "Company") and Donald Klunk, the Company's Chief Accounting Officer and principal accounting offer, mutually agreed that Mr. Klunk would separate from the Company, effective September 18, 2025. Mr. Klunk's departure is not due to any disagreements related to accounting principles or practices, financial statement disclosures, or internal controls with the Company's auditors or management. Following Mr. Klunk's departure, Michael Weiner, the Company's Chief Financial Officer, will take over as the interim principal accounting officer until a successor is announced. The Company expresses its appreciation for Mr. Klunk's contributions and years of service to the Company. Signature Pursuant to the requirements of the Securities Exchange Act of 1934, the registrant has duly caused this report to be signed on its behalf by the undersigned hereunto duly authorized. GENPACT LIMITED Date: September 12, 2025 By: /s/ Heather D. White Name: Heather D. White Title: Senior Vice President, Chief Legal Officer and Secretary